LINK:
Phone number: 415-655-0003
Access Code: 2660 345 3860
Password: Lecture
OBJECTIVES: Upon completion of this activity, the participant should be able to: (1) Identify challenges to clinical trial enrollment and retention (2) Describe the effect of the COVID-19 pandemic on clinical trial design and conduct (3) Explain how clinical observations and questions can lead to broad policy changes
FACULTY DISCLOSURE: David Gerber, MD, has financial interest in Astra-Zeneca, BerGenBio, Karyopharm and Novocur in the form of research funding, Gilead, Medtronic and Walgreens in the form of stock ownership, Abbvie, Astra-Zeneca, Bayer, Catalyst Pharmaceuticals and GSK in the form of consulting/advisory boards, and Daiichi-Sankyo, Summit Therapeutics, Taiho Oncolog in the form of data and safety monitoring boards.
All relevant financial relationships have been mitigated.
PLANNER DISCLOSURE: Austin Metting, MD and Michael Volk, MD, have no relevant financial relationship(s) with companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
ACCREDITATION: The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
DESIGNATION: The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ABIM MOC: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
For information, please contact Aida Munoz-Murphy at [email protected]
- 1.00 American Board of Internal Medicine (ABIM) MOC Part 2Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.00 MOC points in the American Board of Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

- 1.00 AMA PRA Category 1 Credit™The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
- 1.00 Attendance

Facebook
X
LinkedIn
Forward